Understanding the impact of immune-mediated selection on lung cancer evolution
Abstract
Understanding how a tumour evolves and avoids immune recognition is paramount to improving cancer immunotherapy and patient outcome. Here we examine our recent integration of multi-region genomic, transcriptomic, epigenomic, pathology, and clinical data, highlight the need for a systematic examination of immune escape mechanisms, and discuss implications for immunotherapy approaches.
Journal details
Journal British Journal of Cancer
Volume 124
Pages 1615-1617
Available online
Publication date
Full text links
Publisher website (DOI) 10.1038/s41416-020-01232-6
Europe PubMed Central 33623078
Pubmed 33623078
Keywords
Related topics
Type of publication